Thalidomide, A Rational Agent for Treatment of Multicentric Reticulohistiocytosis.

Dermatol Case Rep

Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, Texas, USA.

Published: April 2019

A patient with Multifocal Reticulohistiocytosis (MRH) of skin and joints failed treatment with etanercept, methotrexate, hydroxychloroquine, prednisone, bisphosphonates and hydroxyzine. Long term treatment with thalidomide led to marked improvement in joint and cutaneous manifestations.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289025PMC
http://dx.doi.org/10.35248/2684-124X.19.4.152DOI Listing

Publication Analysis

Top Keywords

thalidomide rational
4
rational agent
4
agent treatment
4
treatment multicentric
4
multicentric reticulohistiocytosis
4
reticulohistiocytosis patient
4
patient multifocal
4
multifocal reticulohistiocytosis
4
reticulohistiocytosis mrh
4
mrh skin
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!